Product Information

BROMFENAC SODIUM 0.09% EYE DRP is a generic product labeled by Fosun Pharma USA Inc., priced at $16.2405 per ML under NDC 72266014201. Its NADAC has been published 316 times since Nov 4, 2020.

FDA first approved this application on Mar 17, 2020. Its Orange Book therapeutic-equivalence code is AT2.

BROMFENAC SODIUM 0.09% EYE DRP

Bromfenac
$16.2405per ML

Strength

.9 mg/mL

NDC

72266014201

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

BROMFENAC SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA211029

FDA Approved

3/17/2020

TE Code

AT2

On Market Since

7/6/2020

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for BROMFENAC SODIUM 0.09% EYE DRP has been published 316 times since Nov 4, 2020, and over the history we have for it it has declined 83.7%. The table below summarizes its recorded NADAC range and movement.

Current price$16.2405 per ML
All-time high$99.6536 (Nov 11, 2020)
All-time low$15.0851 (Oct 21, 2026)
52-week high$20.2795
52-week low$15.0851
Median price$42.2253
Average price$48.0303
Largest weekly change-52.1% (Apr 17, 2024)
Weeks tracked316
Tracking sinceNov 4, 2020

Price History

1W

+7.7%

1M

+3.9%

3M

+3.7%

6M

+1.1%

1Y

-19.9%

3Y

-60.0%

5Y

-74.3%

All

-83.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BROMFENAC SODIUM 0.09% EYE DRP?

The current National Average Drug Acquisition Cost (NADAC) for BROMFENAC SODIUM 0.09% EYE DRP, manufactured by Fosun Pharma USA Inc., is $16.2405 per ML (NDC 72266014201), effective Nov 18, 2026.

How has the price of BROMFENAC SODIUM 0.09% EYE DRP changed over time?

Over the history we have for it, the NADAC for BROMFENAC SODIUM 0.09% EYE DRP has declined 83.7%. It has been tracked across 316 weekly CMS publications since Nov 4, 2020.

What are the highest and lowest recorded NADAC prices for BROMFENAC SODIUM 0.09% EYE DRP?

Since Nov 4, 2020, the NADAC for BROMFENAC SODIUM 0.09% EYE DRP has ranged from a low of $15.0851 (Oct 21, 2026) to a high of $99.6536 (Nov 11, 2020), with a median of $42.2253 per ML.

Are there cheaper alternatives to BROMFENAC SODIUM 0.09% EYE DRP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BROMFENAC SODIUM 0.09% EYE DRP in a comparable dosage form, but none are currently priced below it.

Who manufactures BROMFENAC SODIUM 0.09% EYE DRP?

BROMFENAC SODIUM 0.09% EYE DRP (NDC 72266014201) is labeled by Fosun Pharma USA Inc., and CMS classifies it as a generic product.